OZANIMOD for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where OZANIMOD was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for OZANIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 707 | 9.0% | 0 | 19 |
| Multiple sclerosis relapse | 567 | 7.2% | 1 | 46 |
| Drug ineffective | 517 | 6.6% | 1 | 25 |
| Headache | 490 | 6.2% | 0 | 16 |
| Dizziness | 329 | 4.2% | 1 | 18 |
| Product dose omission issue | 325 | 4.1% | 0 | 17 |
| Nausea | 267 | 3.4% | 0 | 17 |
| Diarrhoea | 253 | 3.2% | 0 | 15 |
| Colitis ulcerative | 246 | 3.1% | 2 | 47 |
| Pain | 228 | 2.9% | 1 | 15 |
| Back pain | 206 | 2.6% | 0 | 10 |
| Adverse event | 178 | 2.3% | 0 | 13 |
| Fall | 165 | 2.1% | 2 | 19 |
| Multiple sclerosis | 164 | 2.1% | 2 | 9 |
| Covid-19 | 163 | 2.1% | 6 | 49 |
Other Indications for OZANIMOD
Multiple sclerosis (4,291)
Colitis ulcerative (1,802)
Product used for unknown indication (1,372)
Relapsing-remitting multiple sclerosis (138)
Relapsing multiple sclerosis (127)
Multiple sclerosis relapse (84)
Colitis (78)
Crohn's disease (72)
Proctitis ulcerative (57)
Clinically isolated syndrome (18)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)